Paul-Albert König

Paul-Albert König's work experience begins with their current role as Co-Founder and Sr. Director Biology at Odyssey Therapeutics since October 2021. Prior to this, they held the position of Dioscure Therapeutics SE Scientific Co-founder at Dioscure Therapeutics starting in November 2020.

Before joining the industry, König worked at The University of Bonn as Core Facility Manager from January 2018 to September 2021. Prior to that, they worked as a Post-Doc at Technische Universität München from April 2014 to December 2017.

König's academic research experience includes being a Ph.D. student at Whitehead Institute from January 2009 to December 2013 and a Research Assistant at Osaka University from October 2007 to September 2008.

Paul-Albert König completed their education at the Technical University of Munich. Paul-Albert obtained a Bachelor of Science in Biochemistry from 2003 to 2006. Subsequently, they pursued a Master of Science in Molecular Biotechnology from 2006 to 2008.